Answers are grounded in this paper and cite their sources.
Sclerosing skin diseases represent a large number of distinct disease entities, which include systemic sclerosis, localized scleroderma, and scleredema adultorum. These pathologies have a common clinical appearance and share histological features. However, the specific interplay between cytokines and growth factors, which activate different mesenchymal cell populations and production of different extracellular matrix components, determines the biomechanical properties of the skin and the clinical features of each disease. A better understanding of the mechanisms underlying these events is prerequisite for developing novel targeted therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Eckes et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: